Literature DB >> 9362450

Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.

H Karasaki1, M Obata, K Ogawa, G H Lee.   

Abstract

The C3H/HeJ (C3H), A/J and BALB/cByJ (BALB) mouse strains are respectively resistant, sensitive and intermediate regarding the induction of lung tumors by urethane. The phenotypic difference between C3H and A/J is largely determined by the Pas1 (Pulmonary adenoma susceptibility 1) gene on chromosome 6, the A/J allele of which dominantly increases the tumor burden. We recently found that BALB mice possess a unique lung tumor resistance gene on chromosome 18, designated Par2 (Pulmonary adenoma resistance 2), which partially, but dominantly suppresses the sensitive phenotype of A/J mice (Oncogene 13: 1599-1604, 1996). It has, however, remained unclear why BALB mice carrying the Par2 gene are significantly more sensitive to urethane-induced lung carcinogenesis than C3H mice that have no dominant lung tumor resistance genes. In the present study, using (C3H x BALB)F1 x C3H backcross mice treated with urethane, we demonstrated that BALB mice possess the disease allele of the Pas1 gene despite their 15-fold more resistance relative to A/J mice (LOD = 22.6). The BALB Par2 allele only significantly reduced the mean lung tumor multiplicity (LOD = 4.4) in the backcross population carrying the BALB allele of Pas1, indicating that the intermediate BALB phenotype may at least in part be the result of interactions between these two dominant genes. While the BALB Pas1 allele increased both the mean multiplicity and size of lung tumors, the BALB Par2 allele affected only the mean tumor multiplicity, implying that they are involved in different stages of multi-step lung carcinogenesis. In addition, we found that 68% of lung tumors from the BALB Pas1-positive backcross mice contained activating point mutations of the Kras2 oncogene, tightly linked to the Pas1 locus, whereas these genetic alterations were absent in tumors from BALB Pas1-negative mice. The Par2 genotype exhibited no effect on this parameter. Since the activating point mutations were observed exclusively in the BALB allele as already reported with lung tumors in (C57BL/6J x BALB/cJ)F1 mice, BALB Pas1 or possibly Kras2 itself may confer selective growth advantage on the affected urethane-initiated lung lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362450     DOI: 10.1038/sj.onc.1201357

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Bronchioloalveolar neoplasia.

Authors:  Hitoshi Kitamura; Koji Okudela
Journal:  Int J Clin Exp Pathol       Date:  2010-11-12

2.  Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720.

Authors:  Natália R Salinas; Camila T Lopes; Patrícia V Palma; Celina T Oshima; Valquiria Bueno
Journal:  Pathol Oncol Res       Date:  2009-02-12       Impact factor: 3.201

Review 3.  The Kras2 oncogene and mouse lung carcinogenesis.

Authors:  Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

4.  Complex genetic control of lung tumorigenesis in resistant mice strains.

Authors:  Alice Dassano; Giulia Pintarelli; Chiara E Cotroneo; Angela Pettinicchio; Elena Forcati; Loris De Cecco; Andrea Borrego; Francesca Colombo; Tommaso A Dragani; Giacomo Manenti
Journal:  Cancer Sci       Date:  2017-10-06       Impact factor: 6.716

5.  Mmp12 Is Upregulated by in utero Second-Hand Smoke Exposures and Is a Key Factor Contributing to Aggravated Lung Responses in Adult Emphysema, Asthma, and Lung Cancer Mouse Models.

Authors:  Alexandra Noël; Zakia Perveen; Rui Xiao; Harriet Hammond; Viviana Le Donne; Kelsey Legendre; Manas Ranjan Gartia; Sushant Sahu; Daniel B Paulsen; Arthur L Penn
Journal:  Front Physiol       Date:  2021-11-29       Impact factor: 4.566

6.  Pulmonary tumors associated with the JC virus T-antigen in a transgenic mouse model.

Authors:  Akira Noguchi; Keiji Kikuchi; Takashi Ohtsu; Mitsuyo Yoshiwara; Yoshiyasu Nakamura; Yohei Miyagi; Huachuan Zheng; Yasuo Takano
Journal:  Oncol Rep       Date:  2013-10-02       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.